A Corollary of Nanoporous Carrier Drug Delivery System: An Updated Perspective
DOI:
https://doi.org/10.37285/ijpsn.2020.13.5.1Abstract
Nanosponges have come into sight as one of the most promising fields of science because of their perceived applications in controlled drug delivery. It has been increasingly investigated to achieve targeted and sustained release of drugs. Nanosponges are one of the novel drug delivery system, which is gaining popularity now days because of their perceived application in controlled and site-specific drug delivery. The fundamental appeal of the nanosponge technology arises from the difficulty experienced with conventional formulations in releasing active ingredients over an extended period of time, unpleasant odor, greasiness and skin irritation. They are tiny sponge-like spherical particles with a large porous surface and are believed to contribute towards reduced side effects, improved stability, increased elegance and enhanced formulation flexibility. The present investigation in the appraisal describes nanosponge technology embracing its method of preparation, characterization, in-vitro and in-vivo evaluation methods along with recent research and future potential.
Downloads
Metrics
Keywords:
nanosponge, controlled drug delivery, polymers, porosity, cross linkers
Downloads
Published
How to Cite
Issue
Section
References
Aggarwal G, Dhawan S and Hari K (2013). Formulation, in vivo and in vivo evaluation of transdermal patches containing risperidone. Drug Dev Ind Pharm 39: 39-50.
Ahmed R, Patil G and Zaheer Z (2013). Nanosponges–a completely new nano-horizon: pharmaceutical applications and recent advances. Drug Dev Ind Pharm 39: 1263-72.
Aldawsari H, Badr-Eldin S, Labib G and H-El-Kamel A (2015). Design and formulation of a topical hydrogel integrating lemongrass-loaded nanosponges with an enhanced antifungal effect: In vivo/in vivo evaluation. Int J Nanomed 10: 893-902.
Ali R, Thirumaleshwar S, Bhosale R and Kulkarni P (2014). Nanosponges- The spanking Accession in Drug Delivery-An Updated Comprehensive Review. Der Pharmacia Sinica 5: 7-21.
Allen T, Ahmed I, Lopes D, Menezes D and Moase E (1995). Immuno liposome-mediated targeting of anti-cancer drugs in vivo. Biochem. Soc.Trans 23: 1073-9.
Amber V, Shailendra S and Swarnalatha S (2008). Cyclodextrin based novel drug delivery systems. J Incl Phenom Macrocycl Chem 62: 23-42.
Ansari K, Torne S, Vavia P, Trotta F and Cavalli R (2011). Cyclodextrin -Based Nanosponges for Delivery of Resveratrol: In vivo Characterization, Stability, Cytotoxicity and Permeation Study. AAPS Pharm Sci Tech 12: 279-86.
Arkas M, Allabashi R, Tsiourvas D, Mattausch E and Perfle R (2006). Organic/inorganic hybrid filters based on dendritic and cyclodextrin nanosponges for the removal of organic pollutants from water. Environ Sci Technol 40: 2771-2777.
Barkai A, Pathak V and Benita S (1990). Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine, Formulation design and process optimization. Drug Dev Ind Pharm 16: 2057-2075.
Bertelli, A (1998). Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 24: 133–8.
Bezawada S, Charanjitha V, Reddy M, Naveenaa V and Gupta R (2014). Nanosponge- A Concise Review for Emerging Trends. Int. J. Pharm. Res. Biomed. Anal 3: 2278-2664.
Bolmal U, Manvi F, Kotha R, Palla S, Paladugu A and Reddy K (2013). Review on Recent Advances in Nanosponge as Drug Delivery System. Int J PharmSci Nanotech 6: 1934-1944.
Cavalli R, Trotta F and Tumiatti W (2006). Cyclodextrin-based nanosponges for drug delivery. J Incl Phenom Macrocycl Chem (56): 209–13.
Chandramouli Y, Sheikh F, Rajalakshmi R, Amaravathi V, Yasmeen R and Chakravarthi N (2012). Preparation and Evaluation of Microsponge Loaded Controlled Release Topical Gel of Acyclovir Sodium. Int. J. Biopharm 3: 96-102.
Che-Ming J, Ronnie H, Jonathan C, Brian T and Liangfang Z (2013). A biomimetic nanosponge that absorbs poreforming toxins. Nat Nanotechnol 8: 336–40.
Chun J, Wei Y, Yu-Cai F, Xin W, Ji-Lin L and Wei W (2009). Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1–FoxO1 pathway. Biochem Biophys Res Commun 93: 378-389.
Davankov V, Ilyin M, Tsyurupa M, Timofeeva G and Dubrovina L (1996). From a Dissolved Polystyrene Coil to Intramolecularly-Hyper-Cross Linked “Nanosponge”. Macromolecules 29: 8398–8403.
Eki S, Lei T, Jingquan L, Zhongfan J, Cyrille B and Thomas P (2009). Biodegradable Star Polymers Functionalized With-Cyclodextrin Inclusion Complexes. Bio macromolecules 10:2699–2707.
Embil K and Nacht S (1996). Themicrosponge delivery system atopical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. J Microencapsule 13: 575–88.
Farooq S and Saini V (2013). Application of novel drug delivery system in the pharmacotherapy of hyperlipidemia. J Chem Pharm Sci 6: 138-46.
Gilardi G, Trota F, Cavalli R, Ferruti P, Ranucci E, Di N, Roggero C and Tumiatti V (2009). Cyclodextrin nanosponges as carrier forbiocatalysts, and in the delivery and release of enzymes, proteins, vaccines and antibodies, WO2009149883 A1.
Gungor S, Erdal M and Aksu B (2013). New formulation strategies in topical antifungal therapy. J Cosmet Dermatol Sci Appl 3: 56-65.
Gupta A, Aggarwal G, Singla S and Arora R (2012). Transfersomes: A novel vesicular carrier for enhanced transdermal delivery of sertraline: Development, characterization, and performance evaluation. Sci Pharm 80: 1061-80.
Gursalkar T, Balaji A and Jain D (2013). Cyclodextrin based nanosponges of pharmaceutical use: A Review. Acta pharm 63: 335-358.
Harth E, Calkins D, Vander E (2011). Multifunctional degradable nanoparticles with control over size and functionalities. WO 2011/082432 A1.
Jabr-Milane L, Vlerken L and Devalapally H (2008). Multifunctional nanocarriers for targeted delivery of drugs and genes. J Controlled Release 130: 121-128.
Jang M, Cai L, Udeani G, Slowing K, Thomas C and Pezzuto J (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218–20.
Jain D, Gursalkar T and Bajaj A (2013). Cyclodextrin based nanosponges for pharmaceutical use. Acta Pharm 63: 335–358.
Jenny A, Merima P, Alberto F and Francesco T (2011). Role of β-cyclodextrin nanosponges in polypropylene photooxidation. Carbohydrate Polymers 86:127–135
Jemal A, Bray F, Melissa M, Frelay J, Elizabeth W and David F (2011). Global Cancer Statistics. Cancer J. Clin 61: 69-90.
Jilsha G and Vishwanand V (2013). Nanosponges: A novel approach of drug delivery system. Int. J Pharm Sci 19: 119-123.
Kadian R (2018). Nanoparticles: a promising drug delivery approach. Asian J Pharm Clin Res 11: 30-5.
Kaur G, Aggarwal G and Harikumar S (2015). Nanosponge: New colloidal drug delivery system for topical delivery. Indo Global J Pharm Sci 5: 53-7.
Khan K, Bhargav E, Reddy K and Sowmya C (2016). Nanosponges: A New Approach for Drug Targetting. Int J Pharm Pharm Res 7: 381-96.
Kilicarslan M and Baykara T (2003). The effect of the drug/polymer ratio on the properties of Verapamil HCl loaded microspheres. Int J Pharm 252: 99-109.
Kopp P (1998). Resveratrol- a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox. Eur J Endocrinol 138: 619-20.
Krishnamurthy K and Rajappa M (2011). Nanosponges: A novel class of drug delivery system. Pharm Sci 15: 11-15.
Kwangjae C, Xu W and Shuming N (2008). Therapeutic Nanoparticles for Drug Delivery in Cancer. Clin Cancer Res 14:1310-1316.
Lala R, Thorat A and Gargote C (2011). Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayur Pharm 2: 1520-1526.
Lamuela-Raventos R, Romero-Perez A, Andrew L, Waterhouse M and Torre-Boronat C (1995). Direct HPLC analysis of cis- and trans-resveratrol and piceid isomers in Spanish red Vitis vinifera wines. J Agric Food Chem 43: 281-3.
Lee C, Wu C, Chiou H, Syu C, Huang C and Yang C (2011). Mesoporous platinum nanosponges as electrocatalysts for the oxygen reduction reaction in an acidic electrolyte. Int J Hydro Energy 36: 6433-6440.
Lilian E and Mansoor M (2006). Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Drug Deliv 3: 205-216.
Maravajhala V, Papishetty S and Bandlapalli S (2010). Nanotechnology in the development of drug delivery system. Int J of Pharmaceutical sci and research 402: 254-247.
Maravajhala V, Papishetty S and Bandlapalli S (2012). Nanotechnology in the development of drug delivery system. Int J pharma Sci. and Res 3: 84-96.
Mathew F, Nair S, Nair K, Soman A, Alias M, Joseph J and Varghese N (2014). A review on targeted drug delivery through nanosponge. Int. J. Uni. Pharm Bio Sci 3: 377-391.
Mishra M, Shikhri M, Sharma R and Goojar M (2011). Optimization, formulation, development and characterization of Eudragit RS 100 loaded microsponges and subsequent colonic delivery. Int J of Drug Discovery And herbal Research 1: 8-13.
Nacht S and Kantz M (1992). Tha Microsponge: A novel topical programmable delivery systems. Topical drug delivery systems 42: 299-325.
Naga S and Nissankararao J (2013). Nanosponges: A versatile drug delivery system. Int J Pharm Life Sci 4: 2920-2925.
Neubert H (2011). Potentials of New Nanocarriers for Der- mal and Transdermal Drug Delivery. European Journal of Pharmacy Biopharmacy 77: 1-2.
Pace A, Rounova C and Hahn O (1997). Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 246: 163-82.
Pathak P and Katiyar V (2007). Multi-Functional Nanoparticles and Their Role in Cancer Drug Delivery – A Review. J Nanotech 3: 1-17.
Patel B, Bagade O, Ramteke K, Patel R and Awasarkar V (2014). An assessment on preparations, Characterization, and poles apart application of nanosponge. Ind. J. pharma. Tech. Res 6: 1898-1907.
Patel C, Tyagi S, Patel K, Patel T, Patel H and Patel P (2014). A Recent Approach of Targeted Drug Delivery System: Nanosponges. Asian J Med Res Pharm Sci 2: 2348-0165.
Patel K and Oswal R (2012). Nanosponge and MicroSponges: A novel drug delivery system, Int J. Res. In Pharm andChem 2: 237-242.
Patil T, Nalawade N, Kakade V and Kale S (2017). Nanosponges: A Novel Targeted Drug Delivery for Cancer Treatment. International Journal of Advance Research and Development 2: 55-62.
Prathma S and Sreeja K (2013). Formulation and evaluation of Voriconazole loaded nanosponges for oral delivery. International journal of drug development and research 5: 55-69.
Pulkkinen M, Pikkarainen J and Wirth T (2008). Three step tumor targeting of paclitaxel using biotinylated PLAPEG nanoparticles and avidin-biotin technology: formulation development and in vivo anticancer activity. Eur J Pharm Biopharm 70: 66-74.
Rajeswari C, Alka A, Javed A and Khar R (2005). Cyclodextrins in drug delivery: an update review. AAPS Pharm Sci Tech 6: E329-E357.
Ramnik S, Nitin B, Jyotsana M and Horemat S (2010). Characterization of Cyclodextrin Inclusion complexes– A Review. J Pharm Sci. Tech 2: 171-183.
Rao M, Bajaj A, Pardeshi A and Aghav S (2012). Investigation of nanoporous colloidal carrier for solubility enhancement of Cefpodoxime proxetil. J pharma Res 5: 2496-2499.
Renuka S and Kamla P (2011). Polymeric Nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 16: 367-376.
Renuka S, Roderick B and Kamla P (2011). Evaluation of the kinetics and mechanism of drug release from Econazole Nitrate nanosponge loaded carbapol hydrogel. Ind J Parm Edu 45: 25-31.
Rita L, Amit T and Chandrashekhar G (2011). Current trends in β-cyclodextrin based drug delivery systems. Int J Res Ayurveda Pharm 2:1520-6.
Romero-Pérez A, Ibern-Gómez M, Lamuela-Raventós R and Torre-Boronat C (1999). Pieced the major resveratrol derivative in grape juices. J Agric Food Chem 26: 1533–6.
Rosalba M, Roberta C, Roberto F, Chiara D, Piergiorgio P, Leigh E, Li S and Roberto P (2011). Antitumor activity of nanosponge-encapsulated Camptotechin in human prostate tumors. Cancer Res 71: 4431.
Sanvicens N and Marco M (2008). Multifunctional nanoparticles – properties and prospects for theiruse in human medicine. Trends Biotechnol 26: 425-433.
Sapino S, Carlotti M, Cavalli R, Ugazio E, Berlier G and Gastaldi L (2013). Photochemical and antioxidant properties of gammaoryzanol in beta-cyclodextrin-based nanosponges. J Incl Phenom Macrocycl Chem 75: 69-76.
Shah C (2013). Cyclodextrin based nanosponges for pharmaceutical use. Acta Pharm 63: 335-358.
Shankar S, Linda P, Loredana S, Francesco T, Vavia P, Dino A, Michele T, Gianpaolo Z and Roberta C (2010). Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eur. J Pharm Biopharm 74: 193-201.
Shankar S, Vavia P, Francesco T and Satyen T (2007). Formulation of β-cyclodextrin based nanosponges of Itraconazole. J Incl Phenom Macrocycl Chem 57: 89–94.
Sharma R and Pathak K (2011). Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation. Pharm Dev Technol 16: 367-376.
Sharma R, Walker R and Pathak K (2011). Evaluation of the kinetics and mechanism of drug release from econazole nitrate nanosponges loaded carbapol hydrogel. Indian J Parm Edu Res 45: 25-31.
Shinde U and Kanojiya S (2014). Serratiopeptidase niosomal gel with potential in topical delivery. J Pharmaceutics 5: 1-9.
Shrigirish M, Prajapati S, Mahor A, Shahi A, Yadav P and Verma A (2014). Nanosponges: A Potential Nanocarrier for Novel Drug Delivery-A Review. Asian Pac J Trop Dis 4:519-S526.
Srinivas P and Reddy J (2015). Formulation and evaluation of isoniazid loaded nanosponges for topical delivery. Pharmaceut Nanotechnol 3: 68-76.
Singh D, Soni G and Prajapati S (2016). Recent advances in nanosponges as drug delivery system: a review. Eur J Pharm Med Res 3: 364-71.
Srinivas P and Sreeja K (2013). Formulation and Evaluation of Varicanazole Loaded Nanosponge for Oral and Topical Delivery. Int. J. Drug Dev. And Res 5: 55-69.
Subramanian S, Singireddy A, Krishnamoorthy K and Rajappan M (2012). Nanosponges: A Novel Class of Drug Delivery System. J Pharm Sci 15: 103-111.
Swaminathan S, Pastero L, Serpe L, Trotta F and Vavia P (2010). Cyclodextrin based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity. Eup J of Pharmaceutics and Biopharmaceutics 74: 193-201.
Swaminathan S, Cavalli R, Trotta F, Ferruti P, Ranucci E and Gerges I (2010). In vivo release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin. J Incl Phenom Macrocycl Chem 68: 183-191.
Tamkhane V and Sharma P, Nanosponge-A Novel Drug Delivery System (2014). Int. Curr. Pharm. J. Res 4: 1186-1193.
Thakre A, Gholse, Y, Kasliwal R (2016). Nanosponges: a novel approach of drug delivery system. J Med Pharm Allied Sci 78: 103-11.
Trotta F and Tumiatti W (2003). Cross-linked polymers based on cyclodextrin for removing polluting agents. Oct 16, 2003, WO 03/085002.
Trotta F (2011). Cyclodextrin nanosponges and their applications, Cyclodextrins in Pharmaceutics, cosmetics, and biomedicine. Current and Future Industrial Application. 1st ed. Wiley & Sons, Italy, pp. 323-42.
Trotta F and Cavalli R (2012). Characterization and applications of new hyper cross-linked cyclodextrin, composite interfaces. Beilstein. J Org Chem 16: 39-48.
Trotta F, Zanetti M and Cavalli R (2012). Cyclodextrin-based nanosponges as drug carriers. Beilstein. J Org Chem 8: 2091–9.
Trotta F, Dianzani C, Caldera F, Mognetti B, Cavalli R (2014). The application of nanosponges to cancer drug delivery. Expert Opinion Drug Delivery 11: 931-41.
Vavia P, Swaminathan S, Trotta F and Cavalla R (2006). Application of nanosponges in drug delivery. In: Proceedings 13th International Cyclodextrin Symposium, Turin, Italy, May 14-17 Springer; Berlin, pp. 207.
Vishwakarma A, Nikam P, Mogal R and Talale S (2014). Nanosponges: A benification for Novel drug Delivery. Int. Jour. Pharm. Tech Sciences 6: 11-20.
Vyas S and Khar R (2002). Controlled Drug Delivery: Concepts and Advances, 1st ed. Vallabh Prakashan, India, pp 411-447.
Wang A, Gu F, Zhang L, Chan J, Moreno A, Mariam R and Omid C (2008). Biofunctionalized targeted nanoparticles for therapeutic applications. Biol. Ther 8:1063-1070.
Weili Q, Wang B, Wang Y, Yang L, Zhang Y and Shao P (2010). Cancer Therapy Based on Nanomaterials and Nanocarrier Systems. J Nanomat 1-9.
Wester R, Patel R, Natch S, Leyden J, Melendres J and Maibach H (1991). Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. J. Am. Acad. Derm 24: 720-726.
Wong V, Fernando G,Wagner A, Zhang J, Kinsel G, Zauscher S and Dyer D (2009). Separation of peptides with polyionic nanosponges for MALDIM Sanalysis. Langmuir 25:1459-65.
Yadav G and Panchory H (2013). Nanosponges–A boon to the targeted drug delivery system. J Drug Delivery Ther 3: 151-155.
Zuruzi S, MacDonald N, Moskovits M and Kolmakov A (2007). Metal oxide "nanosponges" asnchemical sensors: Highly sensitive detection of hydrogen using nanosponge. Titania; Angewandte Chemie 46: 4298-4301.
